Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies

BACKGROUND: Although rates of sustained virologic response (SVR) after hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) surpass 90% in trials and some more “real world” settings, some patients, such as those with substance use disorders, will be challenged to adhere to HCV care...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohl, David A., Allmon, Andrew G., Evon, Donna, Hurt, Christopher, Reifeis, Sarah Ailleen, Thirumurthy, Harsha, Straub, Becky, Edwards, Angela, Mollan, Katie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499638/
https://www.ncbi.nlm.nih.gov/pubmed/28695144
http://dx.doi.org/10.1093/ofid/ofx095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499638/
https://www.ncbi.nlm.nih.gov/pubmed/28695144
http://dx.doi.org/10.1093/ofid/ofx095

Ejemplares similares